Disparate changes in the expression of transient receptor potential vanilloid type 1 receptor mRNA and protein in dorsal root ganglion neurons following local capsaicin treatment of the sciatic nerve in the rat by Szigeti, Csaba et al.
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Abstract—In situ hybridization, quantitative reverse tran-
cription polymerase chain reaction (RT-PCR), immunohisto-
hemistry, and Western blot analysis were applied to study
he changes in expression of the major nociceptive ion chan-
el transient receptor potential vanilloid type 1 receptor
TRPV1) after the perineural application of capsaicin or nerve
ransection. In control rats, quantitative morphometric and
tatistical analyses of TRPV1 protein and mRNA expression
n L5 dorsal root ganglion cells revealed distinct populations
f small (type C) and small-to-medium (type B) neurons,
hich showed very high and moderate levels of TRPV1,
hereas larger (type A) neurons mostly did not express this
eceptor. After either transection or capsaicin treatment of
he sciatic nerve, immunohistochemistry and Western blot-
ing demonstrated a massive (up to 80%) decrease in the
roportion of TRPV1-immunoreactive neurons and TRPV1
rotein at all postoperative survival times. In situ hybridiza-
ion indicated marked decreases (up to 85%) in the propor-
ion of neurons that expressed TRPV1 mRNA after sciatic
erve transection. In contrast, although perineural treatment
ith capsaicin resulted in similar substantial decreases in the
roportions of type B and C neurons of the L5 dorsal root
anglia 3 days postoperatively, a clear-cut tendency to recov-
ry was observed thereafter. Hence, the proportions of both
ype B and C neurons expressing TRPV1 mRNA reached up
o 70% of the control levels at 30 days postoperatively. In
ccord with these findings, quantitative RT-PCR revealed a
arked and significant recovery in TRPV1 mRNA after
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320perineural capsaicin but not after nerve transection. These
observations suggest the involvement of distinct cellular
mechanisms in the regulation of the TRPV1 mRNA expres-
sion of damaged neurons, specifically triggered by the nature
of the injury. The present findings imply that the antinocice-
ptive and anti-inflammatory effects of perineurally applied
capsaicin involve distinct changes in neuronal TRPV1 mRNA
expression and long-lasting alterations in (post)translational
regulation. © 2011 IBRO. Published by Elsevier Ltd. All rights
reserved.
Key words: capsaicin, perineural, TRPV1 mRNA, pain, nerve
transection, in situ hybridization.
Chemosensitive primary sensory neurons, which are sen-
sitive to capsaicin (Jancsó, 1968; Jancsó et al., 1977) and
express the transient receptor potential vanilloid type 1
receptor (TRPV1) (Caterina et al., 1997; Caterina and
Julius, 2001), play a fundamental role in pain mechanisms.
By virtue of their dual functional character, these particular
nociceptive neurons comprise a unique population of pri-
mary afferent neurons, which transmit impulses generated
by noxious stimuli and release neuropeptides from their
peripheral and central terminals in response to stimulation
(Maggi and Meli, 1988; Holzer, 1991; Jancsó, 2009). The
chemosensitive primary afferent neurons, which are selec-
tively sensitive to the stimulatory and neurotoxic effects of
capsaicin, account for around 50% of the dorsal root gan-
glion (DRG) cells and 95% of the unmyelinated dorsal root
fibers in the rat (Jancsó et al., 1977, 2011; Nagy and Hunt,
1983). Previous studies have demonstrated that selective
elimination of these nociceptive afferents either from the
whole animal or from selected regions of the body by the
systemic (neonatal) or localized (perineural) administration
of capsaicin and related vanilloids leads to profound anti-
nociceptive and anti-inflammatory effects (Jancsó et al.,
1977, 1980; Fitzgerald and Woolf, 1982; Gamse et al.,
1982). The perineural application of vanilloid compounds
that results in highly selective regional thermal and chem-
ical analgesia has attracted much interest because of the
promising therapeutic relevance of this intervention. Local
application of capsaicin or resiniferatoxin has been shown
to induce long-lasting increases in the thresholds of noci-
ceptive responses elicited by chemical irritants and intense
heat stimuli (Jancsó et al., 1980; Gamse et al., 1982;
Chung et al., 1985; Kissin et al., 2002). Local treatment
with capsaicin or resiniferatoxin also reduces inflammatory
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C. Szigeti et al. / Neuroscience 201 (2012) 320–330 321thermal and mechanical hyperalgesia and ischemic reac-
tive hyperemia (Kissin et al., 2002; Domoki et al., 2003;
Pospisilova and Palecek, 2006; Holzer, 2008; Jancsó et
al., 2008; Oszlács et al., 2009) and arthritis (Donaldson et
al., 1995). Antidromic vasodilatation and neurogenic in-
flammation, the cardinal local vascular responses of che-
mosensitive afferent endings brought about through stim-
ulation with chemical irritants or antidromic stimulation of
sensory nerves, are completely abolished by such treat-
ment (Jancsó and Király, 1980; Oszlács et al., 2009).
lthough the antinociceptive and anti-inflammatory effects
f locally applied vanilloid compounds have been repeat-
dly demonstrated, the mechanisms of these unique anti-
ociceptive/analgesic effects are still unclear. Electrophys-
ological studies have revealed a selective and long-lasting
eduction of impulse conduction in unmyelinated, but not in
yelinated sensory axons (Jancsó and Such, 1983; Bara-
owski et al., 1986; Pini et al., 1990), associated with a
eduction of polymodal nociceptor units in rat (Welk et al.,
983; Pini et al., 1990), guinea pig, and rabbit (Baranowski
t al., 1986) peripheral nerves. Similar findings have been
eported in monkeys following the treatment of peripheral
erves with capsaicin (Chung et al., 1993). Morphological
nvestigations have disclosed a substantial, but partial re-
uction in the number of unmyelinated sensory (Bara-
owski et al., 1986; Jancsó and Lawson, 1990), but not
utonomic (Jancsó et al., 1987) axons in capsaicin-treated
eripheral nerves and in skin areas innervated by a cap-
aicin-treated peripheral nerve (Jancsó et al., 1980; Dux et
l., 1999). Recent findings indicated that the application of
esiniferatoxin to peripheral nerves induced lasting anal-
esia without noticeable fine structural alterations in the rat
Kissin et al., 2002, 2007). Histochemical and immunohis-
ochemical studies have revealed the marked depletion of
ensory neuropeptides from the spinal ganglia and the
orsal horn of the spinal cord relating to the peripheral
erve treated with a vanilloid agent (Gamse et al., 1982;
ancsó and Lawson, 1988; Oszlács et al., 2009). However,
hanges in the expression of the TRPV1, a molecular
ntegrator of nociception (Winter et al., 1988; Caterina et
l., 1997; Tominaga et al., 1998), which confers capsaicin
vanilloid) sensitivity on chemosensitive primary afferent
eurons (Winter et al., 1988; Caterina et al., 1997; Michael
nd Priestley, 1999) have not been investigated so far after
erineural treatment with vanilloid compounds. The pres-
nt experiments were therefore initiated in an attempt to
ake use of in situ hybridization, quantitative reverse tran-
cription polymerase chain reaction (RT-PCR), immuno-
istochemistry, and Western blot analysis to reveal possi-
le changes in the expression of the TRPV1 following
erineural capsaicin treatment and, for comparison, pe-
ipheral nerve transection.
EXPERIMENTAL PROCEDURES
Adult male Wistar rats weighing 240–260 g at the start of the
experiments were used in this study. The animal house was
maintained under a 12-h light/dark cycle. All experimental proce-
dures were approved by the Ethical Committee for Animal Care of
the University of Szeged and were carried out in accordance with bthe European Communities Council Directive of 24 November
1986 (86/609/EEC). All efforts were made to minimize the number
of animals used and their suffering.
Perineural capsaicin treatment
The rats were anesthetized with chloral hydrate (400 mg/kg, i.p.,
Reanal, Budapest, Hungary). The sciatic nerves were exposed
high in the thigh on both sides, and small pieces of gelfoam
moistened with 0.1 ml of a 1% solution of capsaicin (Fluka, Buchs,
Switzerland) or the same volume of the vehicle (6% ethanol, 8%
Tween 80 in saline) were wrapped around the right and left
nerves, respectively. After 20 min, the gelfoam pieces were re-
moved, the wounds were closed, and the rats were returned to the
animal house. After 3, 14, or 30 days, the animals were again
anesthetized and sacrificed for immunohistochemical and in situ
hybridization analyses.
Peripheral nerve transection
The rats were anesthetized with chloral hydrate (400 mg/kg, i.p.,
Reanal, Budapest, Hungary). The right sciatic nerve was exposed
high in the thigh and transected distal to a ligature. Sham-oper-
ated animals served as controls. After 3, 14, or 30 days, the
animals were again anesthetized and sacrificed for immunohisto-
chemical and in situ hybridization analyses.
In situ hybridization
The synthesis of the cRNA probe and in situ hybridization were
carried out as described by Maniatis et al. (1982), with slight
modifications. To generate TRPV1 mRNA-specific probes, total
mRNA was isolated from rat trigeminal ganglia and was reverse
transcribed by using the universal dT17-adapter primer (5’-
GACTCGAGTCGAGTCGACATCGATTTTTTTTTTTTTTTTT
-3’, M-MuLV reverse transcriptase; Fermentas, Vilnius, Lithuania)
according to the manufacturer’s recommendations. This cDNA
template was used to perform RT-PCR with the following primer
combination: forward 5’-AACCATGGAACAACGGGCTAGC-3’;
reverse 5’-AACTCGAGTTAGAACAGAGCTGACA-3’. The ampli-
fied 255 bp length product was cloned into pcDNA3 vector (Invit-
rogen, Carlsbad, CA, USA). The identity of the amplified product
was confirmed by DNA sequencing and Northern blotting. After
linearization of the vectors, sense and antisense digoxigenin-11-
UTP-labeled cRNA probes were transcribed with T7 or SP6 poly-
merases, using a DIG RNA labeling kit (Boehringer Mannheim,
Mannheim, Germany) according to the manufacturer’s protocol.
For in situ hybridization, DRGs were quickly removed, em-
bedded in Cryomatrix embedding material (Shandon Scientific,
Pittsburgh, PA, USA), and frozen immediately at 70 °C. Serial
frozen sections of DRGs (15 m in thickness) were cut on a
ryostat and thaw-mounted onto 3-aminopropyltriethoxysilane-
oated glass slides. Sections were air-dried and stored at 20 °C
ntil further processing. The specimens were fixed for 5 min in 2
odium chloride–sodium citrate (SSC) buffer (0.3 M NaCl and 0.03
Na-citrate, pH 7.0) containing 4% formaldehyde, washed twice
n 2 SSC buffer for 2 min, permeabilized with 0.1% Triton X100,
ashed again as before, and then rinsed in 0.1 M triethanolamine
ontaining 0.25% acetic anhydride at room temperature for 5 min.
ybridization was performed in 50 l hybridization solution (50%
formamide, 5 sodium chloride–sodium phosphate–EDTA buffer,
1 Denhardt’s reagent, 10% dextran sulfate, 50 mM dithiothreitol,
100 g/ml salmon sperm DNA, and 100 g/ml yeast tRNA con-
aining 200 nmol/ml labeled probe) under parafilm cover slips in a
umidified chamber at 56 °C for 20 h. The sections were exten-
ively rinsed in 2 SSC buffer supplemented with 50% formamide
t 50 °C for 15 min, treated with RNase A at 37 °C for 30 min, and
ashed again in 2 SSC–50% formamide solution at 50 °C. To
lock nonspecific antibody binding, sections were incubated with
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C. Szigeti et al. / Neuroscience 201 (2012) 320–330322buffer 1 (100 mM Tris–HCl and 150 mM NaCl, pH 7.5) containing
5% normal goat serum for 1 h at room temperature, followed by
incubation with alkaline phosphatase-conjugated anti-digoxigenin
antibody (1:2500, Boehringer Mannheim GmbH, Mannheim, Ger-
many) in buffer 1 at 4 °C overnight. Sections were washed in
buffer 1 for 35 min, rinsed in buffer 2 (100 mM Tris–HCl, 100 mM
NaCl, and 50 mM MgCl2, pH 9.5) for 10 min, and developed in
uffer 2 containing 340 g/ml nitro blue tetrazolium and 180 g/ml
-bromo-4-chloro-3-indolyl phosphate for 12 h in a dark chamber.
he reaction was terminated by rinsing the slides in a buffer (10
M Tris–HCl, 1 mM EDTA, pH 8.0) for 10 min. The sections were
overed with glycerol.
Quantitative RT-PCR measurements
To measure changes in the total TRPV1 mRNA expression in
DRGs affected by the transection or capsaicin treatment of the
sciatic nerve, quantitative RT-PCR was used. Rats were termi-
nally anesthetized 3, 14, and 30 days after surgery, and the L5
DRGs were excised and transferred into 1 ml ice-cold Trizol
reagent (Invitrogen, Carlsbad, CA, USA). Total mRNA was iso-
lated by Trizol solution according to the protocol of the manufac-
turer. The extracted total mRNA was reverse transcribed by
using BioRad iScript cDNA Synthesis Kit (Bio-Rad, Hercules,
CA, USA). Specific primers were designed to amplify TRPV1
and beta-2-microglobulin (B2-MG, reference gene) by using the
Primer-Blast open source software (http://www.ncbi.nlm.nih-
.gov/tools/primer-blast). The sequences of the primers were as
follows: B2-MG (NM_012512; reference gene): 5=-TCTCCG-
GTGGATGGCGAGAGT-3= (reverse); 5=-GCTCGCTCGGT-
GACCGTGATC-3= (forward); TRPV1 (NM_031982.1): 5=-
TGTCTTCCGGGCAACGTCCA-3= (reverse); 5=-AAGCGCCT-
GACTGACAGCGA-3= (forward). Primers were synthesized by
Integrated DNA Technologies (Leuven, Belgium). These primers
produced distinct PCR amplification products with length of 129 bp
for TRPV1 and 106 bp for B2-MG, as confirmed by gel-electro-
phoresis. Quantitative RT-PCR was performed in triplicates utiliz-
ing SYBR Green technique (iQ SYBR Green Supermix, Bio-Rad,
Hercules, CA, USA) and BioRad MyiQ5 Real Time Detection
System running the following amplification protocol: 10 min on
95 °C (hot start) followed by 40 amplification cycles (denaturation:
10 s on 95 °C, annealing: 30 s on 56 °C; elongation and detection:
20 s on 72 °C). At the end of the amplification, melt-curve analysis
was also applied to exclude nonspecific fluorescent signals. Rel-
ative quantities of target (TRPV1) mRNAs as compared with the
housekeeping reference gene B2-MG were calculated by using
the Pfaffl-method (Pfaffl, 2001).
TRPV1 immunohistochemistry
The animals were deeply anesthetized and perfused transcardi-
ally with an aldehyde fixative containing 4% paraformaldehyde in
0.1 M phosphate buffer (pH 7.4). The L5 DRG was removed and
postfixed in the same fixative for 2 h and then placed into a
phosphate-buffered 30% sucrose solution. Representative serial
sections of L5 DRGs 15 m in thickness were cut on a cryostat
nd mounted on gelatin-coated glass slides. Sections were rinsed
wice in phosphate-buffered saline (PBS) and incubated overnight
ith the primary antibody (1:1000; rabbit anti-TRPV1 IgG,
CC030, Alomone Labs, Jerusalem, Israel) with 0.3% Triton X100
dded. After rinsing in PBS, the sections were incubated for 2 h
ith the secondary antibody (1:500 biotin-conjugated donkey anti-
abbit IgG, Jackson ImmunoResearch Laboratories, West Grove,
A, USA) diluted in PBS containing 0.3% Triton X100. To visual-
ze the biotin-conjugated antibody, the sections were rinsed and
reated with the Vectastain ABC Elite staining kit (Vector labora-
ories, Burlingame, CA, USA) according to the instructions of the
anufacturer. The sections were dehydrated and covered with
PX mounting medium (Fluka, Buchs, Switzerland). BSemiquantitative densitometry
The sections cut from the DRGs and processed for visualization of
the TRPV1 mRNA by in situ hybridization or the TRPV1 protein by
immunohistochemistry were examined under bright-field illumina-
tion with a DMLB microscope (Leica, Wetzlar, Germany) equipped
with a Nikon Coolpix (Nikon, Tokyo, Japan) digital camera. Under
identical conditions, microphotographs were taken of DRGs relat-
ing to control sciatic nerves and sciatic nerves transected or
treated perineurally with capsaicin following a systemic random
sampling method. The optical density of DRG neurons with clear-
cut nuclei was measured by means of the NIH Scion Image
analysis program. In sections processed for the demonstration of
TRPV1 mRNA, many neurons exhibited granular staining of dif-
ferent intensities in the perikaryon. In contrast, in labeled neurons
the TRPV1 immunoreactivity displayed diffuse staining throughout
the cell bodies and sometimes in their axons. Gray values (GVs)
between 0 and 255 were assigned to each neuron with a clearly
visible nucleus, and their cross-sectional areas (CSAs) were mea-
sured. Relative optical densities (RODs) were determined accord-
ing to the equation RODlog10 (255/(255GV)). The CSA and
OD for each cell were determined and plotted as distribution
istograms or scatter plots.
Classification of DRG neurons
The DRG neurons were classified into different subpopulations by
using a statistical approach. Pilot experiments suggested the ex-
istence of three distinct neuronal subpopulations in the control
DRGs, with different levels of mRNA signal and TRPV1 immuno-
staining. Discriminant analysis was performed to define the ROD
classification effect among the different subpopulations of DRG
neurons. To determine the threshold values of ROD for the sep-
aration of the neuronal subpopulations, the receiver operating
characteristic (ROC) method was applied pairwise (Armitage,
2001; Armitage and Colton, 2005).
Western blot analysis
L5 DRGs were removed from rats 3, 14, and 30 days after
perineural capsaicin treatment or transection of the sciatic nerves
and were homogenized immediately in ice-cold radio immuno
precipitation assay (RIPA) buffer containing 50 mM Tris (pH 8),
150 mM sodium chloride, 1% Triton X-100, 0.5% sodium deoxy-
cholate, 0.1% sodium dodecyl sulfate (SDS), 2 g/ml leupeptin
(Sigma), and 1 g/ml pepstatin (Sigma-Aldrich, St. Louis, MO,
SA). The homogenates were centrifuged at 15000 g for 10 min.
he pellet was discarded, and protein concentrations from the
upernatant were determined according to the method of Lowry et
l. (1951). Protein samples (60 g/well) were separated through a
2% SDS-polyacrylamide gel and transferred to polyvinylidene
ifluoride (PVDF) membrane (Amersham Biosciences, Little Chal-
ont, Buckinghamshire, UK) and blocked for 12 h in 5% nonfat dry
ilk in Tris-buffered saline (TBS) containing 0.1% Tween 20. The
embranes were incubated for 2 h with rabbit anti-TRPV1 (1:500,
hemicon, Temecula, CA, USA) and mouse anti--actin primary
ntibody (1:20000, Santa Cruz Biotechnology, Santa Cruz, CA,
SA) in 1% nonfat dry milk in 0.1% TBS–Tween 20. After three
ashes in 0.1% TBS–Tween 20, the membranes were incubated
or 1 h with the appropriate peroxidase-conjugated secondary
ntibodies (1:2000, Jackson ImmunoResearch Europe Ltd., Cam-
ridgeshire, UK), and washed five times as before. The enhanced
hemiluminescence method (ECL Plus Western blotting detection
eagent; Amersham Biosciences, Little Chalfont, UK) was used to
eveal immunoreactive bands according to the manufacturer’s
rotocol. The films were scanned at 600600 dpi resolution, and
he densitometric quantification was performed by the ImageJ
ublic domain image processing and analysis software (NIH,
ethesda, MD, USA). After subtracting background, TRPV1 band
e
a
C. Szigeti et al. / Neuroscience 201 (2012) 320–330 323densities were normalized to -actin. The ratio of the TRPV1 to
-actin band density was used to calculate the changes in TRPV1
xpression. Results of three independent experiments are shown
s meansSD.
Statistics
The experimental data are shown as meansSD. Statistical anal-
yses were performed with ANOVA and Holm-Sidak, Brown-For-
sythe, or Bonferroni correction methods for post hoc comparisons
by using SPSS (v.18, Statistical Software package, IBM Corpora-
tion, NY, USA). Differences between groups were considered
statistically significant if P0.05.
RESULTS
Localization of TRPV1 mRNA and protein in the L5
DRG of the rat
In the control DRGs, three types of neurons could be
distinguished with different levels of TRPV1 mRNA expres-
sion and TRPV1-immunostaining. Small- to medium-sized
neurons displayed intense and moderate expression lev-
els, whereas particularly the larger neurons were mostly
devoid of TRPV1 mRNA and protein (Fig. 1A–D). The
optimal cut-off point for the TRPV1 mRNA ROD to distin-
guish between group C and the remaining population was
0.40, which provided a specificity of 96% and a sensitivity
of 90%. Similarly, a cut-off value of 0.24 provided the
optimal differentiation between groups A and B (Fig. 1E,
G). Type C and B neurons were characterized by their
small (CSA range: 0–400 m2) and medium sizes (range:
410–900 m2), and high (0.41–1) and moderate (0.25–
0.40) RODs, respectively. The population of type A neu-
rons was composed of cells of various sizes with low
RODs (0–0.24), which hardly exceeded the background
ROD. The type C and B neurons were regarded as ex-
pressing high and moderate levels of TRPV1 mRNA,
whereas type A cells were classified as TRPV1-negative
neurons. The in situ hybridization experiments revealed
that around half of the DRG cells expressed TRPV1 mRNA
in control ganglia. The type C cells accounted for around
19% and the type B cells approximately 29% of the total
neuronal population. About half (51%) of the cells in the
DRGs were clearly negative for TRPV1 mRNA. Although
the majority of the TRPV1 mRNA-negative neurons were
large, some small neurons also exhibited low RODs.
Statistical analysis of the TRPV1-immunopositive neu-
rons revealed three subpopulations of DRG neurons with
respect to their TRPV1 protein content (Fig. 1F, H): the
type C and B neurons were mainly small to medium-sized,
with strong or moderate staining intensity, respectively,
whereas the TRPV1-negative neurons were mostly large.
Effects of perineural capsaicin treatment or
transection of the sciatic nerve on the expression of
the TRPV1 in the L5 DRG of the rat
In the rat, the sensory fibers of the sciatic nerve originate
from the fourth, the fifth, and (to a much lower extent) the
sixth lumbar DRGs (Green, 1968). Up to 85% of the neu-
rons in the fifth lumbar DRG project their axons into the
sciatic nerve (Yip et al., 1984; Aldskogius et al., 1988). Inthe present study, therefore, the fifth lumbar DRG was
chosen to study possible changes in the expression of the
TRPV1 following two types of nerve injury: nerve transec-
tion, a physical injury resulting in neurotmesis, damage to
all types of axons of the sciatic nerve (Seddon, 1943), and
perineural treatment with capsaicin, which produces a se-
lective chemodenervation of C-fiber afferents, but leaves
the continuity of the nerve intact.
Perineural treatment with capsaicin resulted in a rapid
decrease in the expression of TRPV1 mRNA in the neu-
rons of the fifth lumbar DRG, with reductions by about 50%
and 75% in type B and C cells 3 days after the treatment.
However, this initial decrease in TRPV1 expression was
followed by a distinct recovery and the proportion of
TRPV1 mRNA-expressing neurons gradually increased up
to 70% of the control levels toward the end of the study
(Table 1). The experiments using quantitative RT-PCR
confirmed these findings by showing an early and marked
reduction in TRPV1 mRNA expression already 3 days after
perineural capsaicin treatment. However, at later survival
times quantitative RT-PCR measurements revealed a
clear-cut tendency to recovery toward control expression
levels resulting in a marked and statistically significant
increase in TRPV1 mRNA at 30 days (Fig. 2A). Study of
the localization of the TRPV1 protein by means of immu-
nohistochemistry revealed that the proportion of TRPV1-
positive ganglion cells had decreased markedly (to about
30% of the control level) 3 days after perineural capsaicin
treatment, and it remained at that low level throughout the
entire period of the study (Table 1). The reduction in the
proportion of type C cells was especially pronounced, by
about 85%. The analysis of the experimental data clearly
showed the time-dependent and cell type-specific changes
in the expression of TRPV1 mRNA and protein, respec-
tively (Figs. 3 and 4). Western blot analysis of the TRPV1
protein supported the immunohistochemical findings. The
TRPV1 protein was markedly and significantly reduced at
all time points after perineural treatment with capsaicin
(Fig. 2B, C).
Similarly to perineural treatment with capsaicin, periph-
eral nerve transection resulted in rapid and marked reduc-
tions in both TRPV1 mRNA expression and TRPV1 protein
in the type B and C cells of the related fifth lumbar DRG 3
days after surgery. However, in contrast with capsaicin
treatment, the TRPV1 mRNA expression did not recover,
but remained at a low level for the entire remainder of the
study period. In accord with this, the proportion of TRPV1-
immunoreactive neurons dropped to about 30% of the
control level and then remained low throughout the study.
Again, the decreases in TRPV1 mRNA expression and
TRPV1 protein (by about 80%) were especially marked in
the type C cells (Table 1, Fig. 5). In accordance with the
results obtained with in situ hybridization, quantitative RT-
PCR measurements revealed marked and significant re-
ductions in the TRPV1 mRNA expression 3 and 14 days
after nerve transection. TRPV1 mRNA expression showed
some increase after 30 days, but that did not reach signif-
icance (Fig. 2A).
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C. Szigeti et al. / Neuroscience 201 (2012) 320–330324Fig. 1. (A, B) In control ganglia, in situ hybridization (A) and immunohistochemistry (B) revealed small- to medium-sized neurons with intense (arrow)
nd moderate (arrowhead) levels of TRPV1 mRNA and protein, respectively. Larger neurons were usually devoid of both TRPV1 mRNA and protein.
nverse microphotographs; scale bar indicates 25 m. (C, D) Scatter plots of DRG cells, showing the cell sizes and the three separate populations
f neurons with intense, moderate, and very low RODs. (E, G) ROC analysis of TRPV1 mRNA RODs revealed the cut-off values for the separation
f type C and B (E) and type B and A (G) neurons, respectively, and disclosed the high sensitivity and specificity of the analysis involving the use of
OD. (F, H) ROC analysis of the RODs of TRPV1-immunopositive neurons revealed the cut-off values for the separation of type C and B (F) and type
and A (H) neurons, respectively, and disclosed the high sensitivity and specificity of the analysis using ROD.
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Chemosensitive primary sensory neurons which express
the TRPV1 play a fundamental role in the transmission of
nociceptive impulses (Jancsó et al., 1977; Caterina et al.,
1997; Julius and Basbaum, 2001). The level of expression of
the TRPV1 is an important determinant of the nociceptor
function. Increases in TRPV1 mRNA expression and in pe-
ripherally directed axonal transport of TRPV1 protein have
been demonstrated to be associated with neuropathic pain
states and inflammation (Tohda et al., 2001). Conversely,
knockdown of the TRPV1 gene prevents the development
of inflammatory hyperalgesia in the rat (Caterina et al.,
2000; Davis et al., 2000; Kasama et al., 2007). Hence,
TRPV1 antagonism or procedures, which inhibit the acti-
vation of the receptor may produce significant antinocice-
ption. Indeed, the local application of capsaicin and some
other vanilloids directly onto peripheral nerve trunks has
been shown to provide long-lasting and selective chemical
and thermal analgesia, confined to the region innervated
by the affected nerve (Jancsó et al., 1980, 2008, 2011;
Gamse et al., 1982; Fitzgerald and Woolf, 1982; Kissin et
al., 2002; Knotkova et al., 2008). Despite numerous inves-
igations that have made use of perineural capsaicin treat-
ent (Gamse et al., 1982; Gibson et al., 1982; Chung et
l., 1985; Jancsó and Lawson, 1987, 1990; Jancsó et al.,
987; Pini et al., 1990; Jancsó and Ambrus, 1994; Kissin et
l., 2002), the mechanism of analgesia induced by
erineural capsaicin remained unclear.
In the present study, the cell size and the ROD of the
RNA signal and the immunostaining were measured,
nd a statistical approach was applied to classify subpopu-
ations of DRG neurons which express the TRPV1. In
greement with the findings of a previous radioactive in
itu hybridization study (Michael and Priestley, 1999), the
resent findings revealed two subpopulations of small- and
edium-sized neurons that exhibited moderate and high
ntensities of TRPV1 mRNA expression and TRPV1 immu-
oreactivity. The two populations of DRG neurons that
xpressed TRPV1 mRNA or TRPV1 protein could be
learly distinguished through a statistical approach involv-
Table 1. Percentage distribution of TRPV1-expressing (type B, C) an
apsaicin treatment and nerve transection
Neuron type TRPV1 mRNA expression
Control 3 d 14 d
Perineural capsaicin
C 191.28 50.74* 90.62*#
B 292.33 151.03* 150.91*
A 513.13 791.76* 751.51*
Nerve transection
C 181.37 30.36* 20.03*
B 283.10 151.03* 161.72*
A 531.85 821.33* 821.69*
Data are expressed as meansSD.
* Significantly different from the control, P0.05.
# Significantly different from the 3 d value, P0.05.ng ROC analysis based on two characteristic traits ofTRPV1-positive neurons: the cell size and the ROD of the
mRNA signal or the immunostaining for TRPV1. The quan-
titative data demonstrated that a distinct subpopulation of
small DRG neurons displayed a significantly higher TRPV1
mRNA expression than did a larger population of small-
and medium-sized TRPV1-expressing neurons, which ac-
counted for around 19% and 30% of the total neuronal
population, respectively, in the L5 DRGs of the rat.
The main finding of the present study is the demon-
stration of disparate changes in the expression of TRPV1
mRNA and protein in DRG neurons after selective chem-
ical denervation by perineural capsaicin treatment. Fur-
ther, the findings also indicate differences in the regulation
of TRPV1 expression following selective chemical and
physical injuries inflicted upon primary sensory neurons.
In accord with previous reports, peripheral nerve tran-
section resulted in a substantial reduction in the proportion
of TRPV1 mRNA-expressing neurons, which was already
evident 3 days after surgery and persisted for at least 4
weeks in the L5 DRGs. This was closely paralleled by a
significant and persistent decrease in the proportions of
TRPV1-immunoreactive neurons in the L5 DRGs. These
findings corroborate and extend previous reports of paral-
lel reductions in TRPV1 mRNA expression and protein
level in axotomized DRG neurons (Michael and Priestley,
1999). The present study further supported these obser-
vations by measurements of TRPV1 mRNA and protein
using quantitative RT-PCR and Western blotting, respec-
tively. The results indicated marked, significant, and per-
manent reductions in TRPV1 protein confirming the immu-
nohistochemical analysis. TRPV1 mRNA expression was
markedly reduced 3 and 14 days after nerve transection,
but it showed a moderate increase after 30 days, which did
not reach significance.
In sharp contrast, following perineural treatment with cap-
saicin, neurons in the L5 DRG exhibited distinct changes in
TRPV1 mRNA and protein expression and TRPV1 immuno-
staining. Although the expression of TRPV1 mRNA in type C
neurons was markedly decreased 3 days after the treatment,
there was a clear-cut tendency toward recovery after 2
-negative (type A) L5 DRG neurons 3, 14, and 30 d after perineural
TRPV1 immunohistochemistry
Control 3 d 14 d 30 d
1.4*# 171.73 20.56* 40.30* 30.43*
1.2*# 361.00 92.23* 110.72* 120.82*
4.7*# 461.00 892.06* 840.45* 840.44*
0.20* 151.73 20.60* 51.03* 40.26*
1.46* 374.70 161.90* 161.20* 180 65*
1.26* 500.60 802.35* 780.80* 771 00*d TRPV1
30 d
12
20
69
2
16
81weeks, and a statistically significant recovery to about 60%
t
N
f
C. Szigeti et al. / Neuroscience 201 (2012) 320–330326Fig. 2. Quantitative RT-PCR and Western blot analyses of the TRPV1 mRNA and protein expression. (A) Results of three to six independent
experiments demonstrate the time course of changes in TRPV1 mRNA expression measured with quantitative RT-PCR in L5 DRGs following
perineural capsaicin treatment and transection of the sciatic nerve. Note the marked time-dependent increase in TRPV1 mRNA expression following
perineural capsaicin treatment. (B) Representative immunoblots of TRPV1 and -actin proteins in L5 DRGs 3, 14, and 30 d after perineural capsaicin
reatment and transection of sciatic nerve. (C) Results of three independent experiments demonstrate the time course of changes in TRPV1 protein.
ote the marked decreases in the TRPV1 protein at all time points after perineural capsaicin treatment and nerve transection. * Significantly different
rom the control, P0.05. # Significantly different from the 3-day value, P0.05.
aphs.
C. Szigeti et al. / Neuroscience 201 (2012) 320–330 327of the control value was evident after a survival period of 4
weeks. In type B neurons, the TRPV1 mRNA expression
already displayed a significant reduction by 3 days, with a
significant recovery at the end of the study period. The
measurements of total TRPV1 mRNA with quantitative
RT-PCR in DRGs relating to the capsaicin-treated sciatic
nerve confirmed these findings. An early profound de-
crease in TRPV1 mRNA expression was followed by a
clear-cut tendency to recovery resulting in a significant
increase in TRPV1 mRNA expression to about 60% of the
control at the end of the study. Interestingly, however,
Fig. 3. Representative inverse microphotographs of the L5 DRGs, il
transection (E–H) on the TRPV1 mRNA expression (A, B and E, F)
corresponding control (A, C, E, G) DRGs and DRGs ipsilateral to the s
after 14 d. Scale bar indicates 25 m and applies to all microphotogrwhen the TRPV1 immunoreactivity was investigated, atendency to recovery was not observed. The proportions of
TRPV1-immunoreactive type C and type B DRG neurons
decreased to about 12% and 25% of the total control neuro-
nal population after 3 days and remained at these low levels
even after a survival period of 4 weeks. It should be noted that
these changes in the proportions of affected TRPV1 mRNA-
expressing and TRPV1-immunoreactive neurons should be
considered in light of the fact that about 20% of the neurons
in the L5 DRGs are not affected by the lesions for their axons
run in nerves other than the sciatic nerve (Yip et al., 1984;
Aldskogius et al., 1988). These immunohistochemical find-
the effects of perineural capsaicin treatment (A–D) or sciatic nerve
1 immunoreactivity (C, D and G, H). Microphotographs illustrate the
ve treated with capsaicin (B, D) or peripheral nerve transection (F, H)lustrating
or TRPV
ciatic nerings were strongly supported by measurements of the
T
n
t
b
t
C. Szigeti et al. / Neuroscience 201 (2012) 320–330328TRPV1 protein with Western blotting of the L5 DRGs relating
to the capsaicin-treated sciatic nerves. The TRPV1 protein
was markedly decreased already 3 days after the capsaicin
treatment and remained at that low level amounting about
30% of the control throughout the entire period of the study.
The long-lasting, apparently irreversible functional impair-
ments observed after perineural capsaicin treatment, such as
the abolition of chemogenic pain and neurogenic inflamma-
tion, elevated latencies of thermal nociceptive reflexes, and
reduced thermal hyperalgesia, are in accord with the down-
regulation of TRPV1 protein in the DRG neurons.
Several factors must be considered in the interpreta-
tion of the disparate changes brought about by the two
types of nerve injuries, which differ substantially in their na-
ture, that is, nerve transection and perineural capsaicin treat-
ment. Nerve transection, classified as neurotmesis (Seddon,
1943), results in complete severance of the nerve. In con-
Fig. 4. Scatter plots showing the time course of changes in the populati
treatment (A–D) and transection of the ipsilateral sciatic nerve (E–H).
respectively.
Fig. 5. Scatter plots showing the time course of changes in the popula
treatment (A–D) and transection of the ipsilateral sciatic nerve (E–H).
respectively.trast, although leading to a selective chemodenervation of
nociceptive afferents which express the TRPV1 by a mech-
anismwhich involves a slowly progressing dying-back type of
degeneration process (Jancsó and Lawson, 1990; Jancsó,
1992), perineural treatment with capsaicin leaves the nerve
fibers continuous. The exact nature of this denervation pro-
cess is still unclear, but it has been demonstrated that, al-
though practically all capsaicin-sensitive C-fiber afferents are
functionally inactivated, only about half of this population
undergo degeneration, the number of unmyelinated axons in
capsaicin-treated nerves decreasing by only some 30%
(Jancsó and Lawson, 1990; Pini et al., 1990; Jancsó, 1992).
his may imply that after perineural capsaicin, unlike after
erve transection, the surviving axons may provide some
rophic support for the chemically injured neurons, which may
e sufficient to promote the transcription, but not the transla-
ion of TRPV1 mRNA. This assumption is supported by find-
PV1 mRNA-expressing L5 DRG neurons following perineural capsaicin
of decreasing graytone intensities denote type C, B, and A neurons,
RPV1-immunoreactive L5 DRG neurons following perineural capsaicin
of decreasing graytone intensities denote type C, B, and A neurons,ons of TR
Symbolstions of T
Symbols
a
o
n
t
H
e
c
f
t
fi
b
r
p
t
i
v
c
e
(
J
2
i
r
F
J
e
t
n
e
s
t
i
b
H
i
t
m
a
f
t
a
l
i
p
T
n
e
C. Szigeti et al. / Neuroscience 201 (2012) 320–330 329ings indicating that perineural capsaicin treatment exerts a
profound selective, but transient blockade of axonal transport
processes in C-fiber primary afferent neurons (Gamse et al.,
1982; Sántha and Jancsó, 2003). Nerve growth factor (NGF)
reaching the perikarya of the DRG neurons through retro-
grade axonal transport has been shown to play a pivotal role
in the regulation of the expression of TRPV1 mRNA and
protein in DRG neurons. Indeed, deprivation of DRG neurons
of NGF under either in vivo or in vitro conditions has been
shown to lead to a downregulation of TRPV1 mRNA expres-
sion and a loss of sensitivity to capsaicin (Winter et al., 1988;
Aguayo andWhite, 1992; Jancsó and Ambrus, 1994; Jancsó
et al., 1997; Michael and Priestley, 1999).
Similar phenomena involving a mismatch of mRNA
nd protein expressions have been reported, depending
n the developmental and/or functional state of the DRG
eurons. Peripherin mRNA and protein have been shown
o be expressed in parallel in developing DRG neurons.
owever, in mature DRGs, large neurons express periph-
rin mRNA, but not the protein. This was attributed to
hanges in the availability of peripherally derived trophic
actors such as NGF (Goldstein et al., 1996).
Although the distinct changes in the availability of
rophic factors probably best explain, at least in part, the
ndings of the present study, other mechanisms may also
e considered. The replacement of chemically injured neu-
ons by proliferating DRG cells may offer an alternative
ossibility for the partial restitution of the neuron popula-
ions which express TRPV1 mRNA. Indeed, recent find-
ngs demonstrated a restoration of viscerosensory inner-
ation by neurogenesis following a systemic injection of
apsaicin (Czaja et al., 2008), which results in the degen-
ration of large populations of nodose and DRG neurons
Jancsó et al., 1977, 1980, 1985; Ritter and Dinh, 1988;
ancsó and Lawson, 1990; Jancsó, 1992; Hiura et al.,
002). However, this possibility seems unlikely, since little
f any functional recovery was demonstrated after perineu-
al treatment with capsaicin (Jancsó et al., 1980, 2011;
itzgerald and Woolf, 1982; Jancsó and Lawson, 1990;
ancsó, 1992; Dux et al., 1999; Sántha and Jancsó, 2003).
The present study suggests that the regulation of the
xpression of TRPV1 after nerve injury is dependent on
he type of the injury and not on the type of the DRG
euron. Whereas nerve transection resulted in an appar-
ntly long-lasting downregulation of TRPV1 mRNA expres-
ion, the selective chemodenervation of capsaicin-sensi-
ive DRG neurons produced a transient and largely revers-
ble downregulation of TRPV1 mRNA expression as shown
y both in situ hybridization and quantitative RT-PCR.
owever, both treatments induced a seemingly irreversible
nhibition of TRPV1 translation and/or changes in post-
ranslational processing, resulting in a massive and per-
anent loss of TRPV1 protein from DRG neurons, as
ssessed by immunohistochemistry and Western blotting
ollowing perineural capsaicin treatment or nerve transec-
ion. The present findings may have important implications
s concerns the mechanism(s) of chemically induced se-
ective analgesia. The results point to the possibility that
nterfering with the translation and/or post-translationalrocessing of nociceptive ion channels, such as the
RPV1, by using specific siRNAs, for example, may offer a
ovel approach to the production of antinociception by
mploying molecular biological tools.
Acknowledgments—This work was supported in part by OTKA PD
73259, TAMOP 4.2.1/B-09/1/KONV-2010-0005, and TAMOP
4.2.2/B-10/1-2010-0012. The authors are grateful to Z. Ambrus
and É. Hegyeshalmi for their expert technical assistance and D.
Durham for linguistic correction of the article.
REFERENCES
Aguayo LG, White G (1992) Effects of nerve growth factor on TTX- and
capsaicin-sensitivity in adult rat sensory neurons. Brain Res
570:61–67.
Aldskogius H, Wiesenfeld-Hallin Z, Kristensson K (1988) Selective
neuronal destruction by ricinus-communis agglutinin-I and its use
for the quantitative-determination of sciatic-nerve dorsal-root gan-
glion-cell numbers. Brain Res 461:215–220.
Armitage P (2001) Biostatistics in clinical trial. Chichester: John Whiley.
Armitage P, Colton T (2005) Encyclopedia of biostatistics. Chichester:
John Wiley.
Baranowski R, Lynn B, Pini A (1986) The effects of locally applied
capsaicin on conduction in cutaneous nerves in four mammalian
species. Br J Pharmacol 89:267–276.
Caterina MJ, Julius D (2001) The vanilloid receptor: a molecular
gateway to the pain pathway. Annu Rev Neurosci 24:487–517.
Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-
Zeitz KR, Koltzenburg M, Basbaum AI, Julius D (2000) Impaired
nociception and pain sensation in mice lacking the capsaicin re-
ceptor. Science 288:306–313.
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD,
Julius D (1997) The capsaicin receptor: a heat-activated ion chan-
nel in the pain pathway. Nature 389:816–824.
Chung JM, Lee KH, Hori Y, Willis WD (1985) Effects of capsaicin
applied to a peripheral nerve on the responses of primate spino-
thalamic tract cells. Brain Res 329:27–38.
Chung JM, Paik KS, Kim JS, Nam SC, Kim KJ, Oh UT, Hasegawa T,
Chung K, Willis WD (1993) Chronic effects of topical application of
capsaicin to the sciatic nerve on responses of primate spinotha-
lamic neurons. Pain 53:311–321.
Czaja K, Burns GA, Ritter RC (2008) Capsaicin-induced neuronal
death and proliferation of the primary sensory neurons located in
the nodose ganglia of adult rats. Neuroscience 154:621–630.
Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P,
Harries MH, Latcham J, Clapham C, Atkinson K, Hughes SA,
Rance K, Grau E, Harper AJ, Pugh PL, Rogers DC, Bingham S,
Randall A, Sheardown SA (2000) Vanilloid receptor-1 is essential
for inflammatory thermal hyperalgesia. Nature 405:183–187.
Domoki F, Sántha P, Bari F, Jancsó G (2003) Perineural capsaicin
treatment attenuates reactive hyperaemia in the rat skin. Neurosci
Lett 341:127–130.
Donaldson LF, McQueen DS, Seckl JR (1995) Neuropeptide gene
expression and capsaicin-sensitive primary afferents: mainte-
nance and spread of adjuvant arthritis in the rat. J Physiol 486:
473–482.
Dux M, Sann H, Schemann M, Jancsó G (1999) Changes in fibre
populations of the rat hairy skin after selective chemodenervation
by capsaicin. Cell Tissue Res 296:471–477.
Fitzgerald M, Woolf CJ (1982) The time course and specificity of the
changes in the behavioural and dorsal horn cell responses to
noxious stimuli following peripheral nerve capsaicin treatment in
the rat. Neuroscience 7:2051–2056.
Gamse R, Petsche U, Lembeck F, Jancsó G (1982) Capsaicin applied
to peripheral nerve inhibits axoplasmic transport of substance P
and somatostatin. Brain Res 239:447–462.
C. Szigeti et al. / Neuroscience 201 (2012) 320–330330Gibson SJ, McGregor G, Bloom SR, Polak JM, Wall PD (1982) Local
application of capsaicin to one sciatic nerve of the adult rat induces
a marked depletion in the peptide content of the lumbar dorsal
horn. Neuroscience 7:3153–3162.
Goldstein ME, Grant P, House SB, Henken DB, Gainer H (1996)
Developmental regulation of two distinct neuronal phenotypes in
rat dorsal root ganglia. Neuroscience 71:243–258.
Green EC (1968) Anatomy of the rat. New York: Hafner.
Hiura A, Nakae Y, Nakagawa H (2002) Cell death of primary afferent
nerve cells in neonatal mice treated with capsaicin. Anat Sci Int
77:47–50.
Holzer P (1991) Capsaicin: cellular targets, mechanisms of action, and
selectivity for thin sensory neurons. Pharmacol Rev 43:143–201.
Holzer P (2008) The pharmacological challenge to tame the transient
receptor potential vanilloid-1 (TRPV1) nocisensor. Br J Pharmacol
155:1145–1162.
Jancsó G (1992) Pathobiological reactions of C-fibre primary sensory
neurones to peripheral nerve injury. Exp Physiol 77:405–431.
Jancsó G (2009) Neurogenic inflammation in health and disease. In:
Neuroimmune biology, Vol. 8 (Bérczi I, Szentiványi A, eds)Amster-
dam: Elsevier.
Jancsó G, Ambrus A (1994) Capsaicin sensitivity of primary sensory
neurones and its regulation. In: Peripheral neurons in nociception:
physio-pharmacological aspects, Vol. 1 (Besson JM et al., eds), pp
71–87. Paris: John Libbey Eurotext.
Jancsó G, Dux M, Oszlács O, Sántha P (2008) Activation of the
transient receptor potential vanilloid-1 (TRPV1) channel opens the
gate for pain relief. Br J Pharmacol 155:1139–1141.
Jancsó G, Juhász A, Dux M, Sántha P, Domoki F (1997) Axotomy
prevents capsaicin-induced sensory ganglion cell degeneration.
Primary Sensory Neuron 2:159–165.
Jancsó G, Király E (1980) Distribution of chemosensitive primary
sensory afferents in the central nervous system of the rat. J Comp
Neurol 190:781–792.
Jancsó G, Király E, Jancsó-Gábor A (1977) Pharmacologically in-
duced selective degeneration of chemosensitive primary sensory
neurones. Nature 270:741–743.
Jancsó G, Király E, Jancsó-Gábor A (1980) Direct evidence for an
axonal site of action of capsaicin. Naunyn Schmiedebergs Arch
Pharmacol 313:91–94.
Jancsó G, Király E, Joó F, Such G, Nagy A (1985) Selective degen-
eration by capsaicin of a subpopulation of primary sensory neurons
in the adult rat. Neurosci Lett 59:209–214.
Jancsó G, Lawson SN (1987) Perineural capsaicin treatment of the
sciatic-nerve in adult-rats causes transganglionic changes in the
spinal-cord dorsal horn. J Physiol 394:109–109.
Jancsó G, Lawson SN (1988) Ganglionic changes associated with
transganglionic degeneration of capsaicin-sensitive primary sen-
sory afferents—a quantitative morphometric and immunohisto-
chemical study. Reg Peptides 22:97–97.
Jancsó G, Lawson SN (1990) Transganglionic degeneration of cap-
saicin-sensitive C-fiber primary afferent terminals. Neuroscience
39:501–511.
Jancsó G, Oszlács O, Sántha P (2011) The capsaicin paradox: pain
relief by an algesic agent. Anti-Inflammatory and Anti-Allergy
Agents in Medicinal Chemistry 10:52–56.
Jancsó G, Such G (1983) Effects of capsaicin applied perineurally to
the vagus nerve on cardiovascular and respiratory functions in the
cat. J Physiol 341:359–370.
Jancsó G, Such G, Rödel C (1987) A new approach to selective
regional analgesia. In: Trends in cluster headache (Sicuteri F,
Vecchiet L, Fanciullacci M, eds), pp 59–68. Amsterdam, New
York: Excerpta Medica.
Jancsó N (1968) Desensitization with capsaicin as a tool for studying
the function of pain receptors. In: Pharmacology of pain (Lim RKS,
ed), pp 33–55. Oxford: Pergamon Press.
(Accepted 29 Octo
(Available online 9 NovJulius D, Basbaum AI (2001) Molecular mechanisms of nociception.
Nature 413:203–210.
Kasama S, Kawakubo M, Suzuki T, Nishizawa T, Ishida A, Nakayama
J (2007) RNA interference-mediated knock-down of transient re-
ceptor potential vanilloid 1 prevents forepaw inflammatory hyper-
algesia in rat. Eur J Neurosci 25:2956–2963.
Kissin I, Bright CA, Bradley EL Jr. (2002) Selective and long-lasting
neural blockade with resiniferatoxin prevents inflammatory pain
hypersensitivity. Anesth Analg 94:1253–1258.
Kissin I, Freitas CF, Mulhern HL, DeGirolami U (2007) Sciatic nerve
block with resiniferatoxin: an electron microscopic study of unmy-
elinated fibers in the rat. Anesth Analg 105:825–831.
Knotkova H, Pappagallo M, Szállási A (2008) Capsaicin (TRPV1 ag-
onist) therapy for pain relief: farewell or revival? Clin J Pain
24:142–154.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein mea-
surement with the Folin phenol reagent. J Biol Chem 193:265–275.
Maggi CA, Meli A (1988) The sensory-efferent function of capsaicin-
sensitive sensory neurons. Gen Pharmacol 19:1–43.
Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning: a labo-
ratory manual. NY: Cold Spring Harbor Laboratory.
Michael GJ, Priestley JV (1999) Differential expression of the mRNA
for the vanilloid receptor subtype 1 in cells of the adult rat dorsal
root and nodose ganglia and its downregulation by axotomy.
J Neurosci 19:1844–1854.
Nagy JI, Hunt SP (1983) The termination of primary afferents within
the rat dorsal horn: evidence for rearrangement following capsaicin
treatment. J Comp Neurol 218:145–158.
Oszlács O, Sántha P, Jancsó G (2009) Long-lasting antinociceptive
and anti-inflammatory effects of N-oleoyldopamine, an endoge-
nous vanilloid. Neuropeptides 43:413–413.
Pfaffl MW (2001) A new mathematical model for relative quantification
in real-time RT-PCR. Nucleic Acids Res 29: e45.
Pini A, Baranowski R, Lynn B (1990) Long-term reduction in the
number of C-fibre nociceptors following capsaicin treatment of a
cutaneous nerve in adult rats. Eur J Neurosci 2:89–97.
Pospisilova E, Palecek J (2006) Post-operative pain behavior in rats is
reduced after single high-concentration capsaicin application. Pain
125:233–243.
Ritter S, Dinh TT (1988) Capsaicin-induced neuronal degeneration:
silver impregnation of cell bodies, axons, and terminals in the
central nervous system of the adult rat. J Comp Neurol 271:79–90.
Sántha P, Jancsó G (2003) Transganglionic transport of cholerag-
enoid by capsaicin-sensitive C-fibre afferents to the substantia
gelatinosa of the spinal dorsal horn after peripheral nerve section.
Neuroscience 116:621–627.
Seddon HJ (1943) Three types of nerve injury. Brain 66:237–246.
Tohda C, Sasaki M, Konemura T, Sasamura T, Itoh M, Kuraishi Y
(2001) Axonal transport of VR1 capsaicin receptor mRNA in pri-
mary afferents and its participation in inflammation-induced in-
crease in capsaicin sensitivity. J Neurochem 76:1628–1635.
Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skin-
ner K, Raumann BE, Basbaum AI, Julius D (1998) The cloned
capsaicin receptor integrates multiple pain-producing stimuli. Neu-
ron 21:531–543.
Welk E, Petsche U, Fleischer E, Handwerker HO (1983) Altered
excitability of afferent C-fibres of the rat distal to a nerve site
exposed to capsaicin. Neurosci Lett 38:245–250.
Winter J, Forbes CA, Sternberg J, Lindsay RM (1988) Nerve growth
factor (NGF) regulates adult rat cultured dorsal root ganglion neu-
ron responses to the excitotoxin capsaicin. Neuron 1:973–981.
Yip HK, Rich KM, Lampe PA, Johnson EM (1984) The effects of nerve
growth-factor and its antiserum on the postnatal-development and
survival after injury of sensory neurons in rat dorsal-root ganglia.
J Neurosci 4:2986–2992.ber 2011)
ember 2011)
